MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here ?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Chancellor welcomes decision to give Credit Suisse ￡44.5bn lifeline as shares bounce back.
Indonesian wealth fund INA eyes $1bn investments this year. (FS)?
You can access today’s complete newsletter?here .
Scroll down for more…
Alimentation Couche-Tard , a convenience store company, agreed to acquire European retail assets of TotalEnergies , a multi-energy company, for €3.1bn ($3.3bn).
"We are excited to welcome the TotalEnergies employees and stores into the Couche-Tard family. As we learned more about their business, it became clear that we share the same customer-centric approach, values, and focus on an engaged workforce. We have deep respect for its operations, management, and people as well as great confidence that by joining forces together, we will build a winning global retail operation in the region. We see this as a strong geographical fit with our existing European network, which will allow us to grow together in some of Europe's strongest economies and move forward in our vision to become the world's preferred destination for convenience and mobility," Brian Hannasch, Alimentation Couche-Tard President and CEO.
Debt Financing is provided by National Bank Financial , Bank of Nova Scotia and RBC Capital Markets .
Shareholders of YS Biopharma and Summit Healthcare Acquisition announced that the SPAC business combination was approved at an extraordinary general meeting. YS Biopharma will remain as the combined company and its shares and warrants are expected to begin trading on the Nasdaq Capital Market under the symbols "YS" and "YSBPW."
"Going public is a natural step for YS Biopharma right now. We are pleased that the shareholders of Summit have, through approval of the business combination, reaffirmed their belief in our vision and future for the company. We have built an innovative portfolio and recorded strong product revenue growth and financial performance over recent years. Looking forward, our strategy is to drive continuous organic growth through innovation and geographic expansion for our pipeline products, combined with disciplined investment in new technology and clinical development. The business combination with Summit brings us one step closer to realizing our foremost goals as a leading global biopharma company," David Hui Shao, YS Biopharma CEO.
YS Biopharma is advised by Jingtian & Gongcheng , Maples Group and Wilson Sonsini Goodrich & Rosati . Summit Healthcare is advised by Cooley LLP (led by? Steven Holm ) and Ogier .
Grupo Murano , a real estate developer, agreed to go public via a SPAC merger with HCM Acquisition Co , a blank cheque company, in an $810m deal.
“Our experience and view of the market demonstrate to us that Mexico will provide a platform for robust growth that will facilitate expansion abroad over time. We are thrilled to be partnering with HCM to facilitate and expedite growth fueled by access to US capital markets,” Elias Sacal, Murano Chairman.
Murano is advised by Clifford Chance , Nader, Hayaux & Goebel and ICR . HCM Acquisition is advised by Cohen & Company Capital Markets , JVB Financial Inc , Abogados Galicia , King & Spalding and Loyens & Loeff (led by? Michel van Agt ).
Chancellor welcomes decision to give Credit Suisse ￡44.5bn lifeline as shares bounce back.
Chancellor Jeremy Hunt has welcomed the Swiss central bank's decision to give 瑞信 a lifeline of CHF50bn (￡44.5bn).?
The bank was taking decisive action to pre-emptively strengthen its liquidity with the central bank loan after shares plunged about 30% - intensifying fears of a global financial crisis,?SkyNews ?reported.
Indonesian wealth fund INA eyes $1bn investments this year. (FS)
The Indonesian Investment Authority, the country’s sovereign wealth fund, is targeting investments worth $1bn this year, mainly across the energy, infrastructure, digital, and healthcare space.
DealStreetAsia? reported that, Arief Budiman, INA Deputy CEO, said as of 2022-end, INA had secured investment commitments worth $27bn, including $10bn from the UAE; $3bn from the Chinese Silk Road Fund; $500m from Denmark SWF IFU; $3bn from Caisse de dép?t et placement du Québec (CDPQ) , APG Asset Management and a unit of the Abu Dhabi Investment Authority (ADIA) for a toll road platform; and $7.5bn from DP World .
Interested to find more??Sign up here ?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here .